NOTCH1 and glioblastoma: However, treatment with Notch1 inhibitor DAPT restored the proliferation and migration abilities induced by low expression of Smarcd1, suggesting that downregulated Smarcd1 aggravated glioblastoma malignancy potentially via enabled Notch1 pathway.